Cervicovaginal fetal fibronectin as a marker for preterm delivery: A meta-analysis

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 5, 1999, Pages 1169-1176

  Leitich, Harald ^a   Egarter, C ^b   Kaider, A ^b   Hoblagschwandtner, M ^b   Berghammer, P ^b   Husslein, P ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Fetal fibronectin; Meta analysis; Preterm delivery

Indexed keywords

FIBRONECTIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PREMATURE LABOR; PRIORITY JOURNAL; UTERINE CERVIX;

EID: 0033000903     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70612-5     Document Type: Article

References (34)

1. 1. Lockwood CL, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-74.
2. 2. McLean M, Walters WA, Smith R. Prediction and early diagnosis of preterm labor: a critical review. Obstet Gynecol Surv 1993;48:209-25.
3. 3. Revah A, Sue-A-Quan A, Hannah M. Fetal fibronectin as a predictor of preterm birth: a systematic review of the literature [abstract]. Am J Obstet Gynecol 1997;176:853.
4. 4. Chien PFW, Khan KS, Ogston S, Owen P. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. Br J Obstet Gynaecol 1997;104:436-44.
5. 5. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991;10:1665-77.
6. 6. Bartnicki J, Casal D, Kreaden US, Saling E, Vetter K. Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth-weight infants. Am J Obstet Gynecol 1996;174:971-4.
7. 7. Benattar C, Taieb J, Fernandez H, Lindenbaum A, Frydman R, Ville Y. Rapid fetal fibronectin swab-test in preterm labor patients treated by betamimetics. Eur J Obstet Gynecol Reprod Biol 1997;72:131-5.
8. 8. Bittar RE, Yamasaki AA, Sasaki S, Zugaib M. Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996;175:178-81.
9. 9. Burrus DR, Ernest JM, Veille JC. Fetal fibronectin, interleukin-6 and C-reactive protein are useful in establishing prognostic sub-categories of idiopathic preterm labor. Am J Obstet Gynecol 1995;173:1258-62.
10. 10. Faron G, Boulvain M, Lescrainier JP, Vokaer A. A single cervical fetal fibronectin screening test in a population at low risk for preterm delivery: an improvement on clinical indicators? Br J Obstet Gynaecol 1997;104:697-701.
11. 11. Goffeng AR, Holst E, Milsom I, Lindstedt G, Lundberg PA, Andersch B. Fetal fibronectin and microorganisms in vaginal fluid of women with complicated pregnancies. Acta Obstet Gynecol Scand 1997;76:521-7.
12. 12. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The preterm prediction study: Fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996;87:643-8.
13. 13. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, et al. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Medicine Units Network. Am J Obstet Gynecol 1996;175:1047-53.
14. 14. Greenhagen JB, Van Wagoner J, Dudley D, Hunter C, Mitchell M, Logsdon V, et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol 1996;175:1054-6.
15. 15. Hellemans P, Gerris J, Verdonk P. Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol 1995;102:207-12.
16. 16. Hux CH, Trolice MP, Kadar N. The value of a single fetal fibronectin assay as a screen for preterm labor and delivery. J Matern Fetal Med 1995;4:100-4.
17. 17. Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141-5.
18. 18. Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak FA, et al. Detection of tumor necrosis factor-α, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 1994;171:5-10.
19. 19. Langer B, Boudier E, Schlaeder G. Cervico-vaginal fetal fibronectin: predictive value during false labor. Acta Obstet Gynecol Scand 1997;76:218-21.
20. 20. Leeson SC, Maresh MJA, Martindale EA, Mahmood T, Muotone A, Hawkes N, et al. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynaecol 1996;I03:48-53.
21. 21. Lockwood CJ, Wein R, Lapinski R, Casal D, Berkowitz G, Alvarez M, et al. The presence of cervical and vaginal fetal Fibronectin predicts preterm delivery in an inner-city obstetric population. Am J Obstet Gynecol 1993;169:798-804.
22. 22. Malak TM, Sizmur F, Bell SC, Taylor DJ. Fetal fibronectin in cervicovagitiul secretions as a predictor of preterm birth. Br J Obstet Gynaecol 1996;103:648-53.
23. 23. Morrison JC, Allbert JR, McLaughlin BN, Whitworth NS, Roberts WE, Martin RW. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993;168:538-42.
24. 24. Morrison JC, Neaf RW 3rd, Botti JJ, Katz M, Belluomini JM, McLaughlin BN. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstet Gynecol 1996; 87:649-55.
25. 25. Nageotte MF, Casal D, Senyei AE. Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 1994;170:20-5.
26. 26. Parker J, Bell R, Brennecke S. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labor as a predictor of delivery before 34 weeks' gestation. Aust N Z J Obstet Gynaecol 1995;35:257-61.
27. 27. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm births in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997;177:13-8.
28. 28. Rizzo G, Capponi A, Arduini D, Lorido C, Romanini C. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996;175:1146-51.
29. 29. Rozenberg P, Goffinet F, Malagrida L, Giudicelli Y, Perdu M, Houssin I, et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1997;176:196-9.
30. 30. Senden IP, Owen P. Comparison of cervical assessment, fetal fibronectin and fetal breathing in the diagnosis of preterm labor. Clin Exp Obstet Gynecol 1996;23:5-9.
31. 31. Tolino A, Ronsini S, Zullo F, Pellicano M, Regine V, Nappi C. Fetal fibronectin as a screening test for premature delivery in multiple pregnancies. Int J Obstet Gynecol 1996;52:3-7.
32. 32. Timor-Tritsch IE, Boozarjomehri F, Masakowski Y, Monteagudo A, Chao CR. Can a "snapshot" sagittal view of the cervix by transvaginal ultrasonography predict active preterm labor? Am J Obstet Gynecol 1996;174:990-5.
33. 33. Higby K, Xenakis EM, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:1247-59.
34. 34. Egarter C, Leitich H, Husslein P, Kaider A, Schemper M. Adjunctive antibiotic treatment in preterm labor and neonatal morbidity: a meta-analysis. Obstet Gynecol 1996;88:303-9.